Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States-Reference-Cited by-同舟云学术

Two-year persistence and compliance with osteoporosis therapies among postmenopausal women in a commercially insured population in the United States

Published:2017-02-28 Issue:1 Volume:12 Page:
ISSN:1862-3522
Container-title:Archives of Osteoporosis
language:en
Short-container-title:Arch Osteoporos

Author:

Durden Emily,Pinto Lionel,Lopez-Gonzalez Lorena,Juneau Paul,Barron Richard

Publisher

Springer Science and Business Media LLC

Subject

Orthopedics and Sports Medicine

Link

http://link.springer.com/article/10.1007/s11657-017-0316-5/fulltext.html

Reference28 articles.

1. World Health Organization (2003) Prevention and management of osteoporosis: WHO Technical Report series no. 92. http://whqlibdoc.who.int/trs/who_trs_92pdf . Accessed 02 Feb 2016

2. Cummings SR, Melton LJ (2002) Epidemiology and outcomes of osteoporotic fractures. Lancet 359:1761–1767. doi: 10.1016/s0140-6736(02)08657-9

3. Scott LJ (2014) Denosumab: a review of its use in postmenopausal women with osteoporosis. Drugs Aging 31:555–576. doi: 10.1007/s40266-014-0191-3

4. National Osteoporosis Foundation (2014) 2014 Clinician’s guide to prevention and treatment of osteoporosis. National Osteoporosis Foundation, Washington, DC http://nof.org/files/nof/public/content/file/2791/upload/919.pdf . Accessed 04 Feb 2016

5. Caro JJ, Ishak KJ, Huybrechts KF, Raggio G, Naujoks C (2004) The impact of compliance with osteoporosis therapy on fracture rates in actual practice. Osteoporos Int 15:1003–1008. doi: 10.1007/s00198-004-1652-z

Cited by 81 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness of denosumab vs alendronate among postmenopausal women with osteoporosis;Journal of Bone and Mineral Research;2024-05-16

2. Treatment patterns in women with postmenopausal osteoporosis using abaloparatide: a real-world observational study;Osteoporosis International;2024-04-24

3. Bisphosphonate alternative regimens for the prevention of osteoporotic fragility fractures: BLAST-OFF, a mixed-methods study;HEALTH TECHNOL ASSES;2024

4. High‐dose vitamin D to attenuate bone loss in patients with prostate cancer on androgen deprivation therapy: A phase 2 RCT;Cancer;2024-03-23

5. Diagnosis and Management of Osteoporosis: A Comprehensive Review of Guidelines;Obstetrical & Gynecological Survey;2023-11